Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
  • For Authors
    • Call for Papers
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
  • For Authors
    • Call for Papers
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Article

Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma

Hong Xu, Yueming Chen, Xueyan Dong and Xianjun Wang
Hong Xu
Laboratory Medicine, Hangzhou First People's Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yueming Chen
Laboratory Medicine, Hangzhou First People's Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cymwly1972@163.com
Xueyan Dong
Laboratory Medicine, Hangzhou First People's Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianjun Wang
Laboratory Medicine, Hangzhou First People's Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-17-0770
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background:Increasing studies suggest that lncRNAs involving in carcinogenesis of human cancers, which might be used as diagnostic biomarkers for cancers Methods:Three hundred and one participants were recruited in the first part of the study including HCC group (n = 60), LC group (n = 85), CHB group (n = 96) and healthy subjects (n = 60). In the second part, we collected 55 HCC patients, 60 CHB patients and 60 healthy subjects as an independent cohort to validate the ability of the experiential lncRNAs for identifying HCC from CHB. Results:The results showed the levels of lnRNAs in the HCC group were significantly higher than those in the other groups (all P < 0.05). A high ENSG00000258332.1 level in HCC was associated with portal vein tumor emboli, lymph node metastasis, TNM stage and overall survival (OS) (all P < 0.05); and a high LINC00635 level was related to lymph node metastasis, TNM stage and OS (all P < 0.05). ENSG00000258332.1 discriminated HCC from CHB gaining an AUC of 0.719 (cut-off value of 1.345); LINC00635 gained an AUC of 0.750 (cut-off value of 1.690). Furthermore, the AUC for the combination of 2 lncRNAs and AFP (cut-off value of 20 μg/L) was 0.894. The abilities of the 2 lncRNAs for identifying HCC from CHB were validated by an independent cohort. Conclusions:The results suggested that the combination of lncRNAs and AFP may be a valuable assay in diagnosis and prognosis of HCC. Impact:Our data will shed light on exosomal lncRNAs as biomarkers for HCC.

  • Received August 25, 2017.
  • Revision received December 9, 2017.
  • Accepted April 2, 2018.
  • Copyright ©2018, American Association for Cancer Research.
PreviousNext
Back to top

Published OnlineFirst April 12, 2018
doi: 10.1158/1055-9965.EPI-17-0770

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma
Hong Xu, Yueming Chen, Xueyan Dong and Xianjun Wang
Cancer Epidemiol Biomarkers Prev April 12 2018 DOI: 10.1158/1055-9965.EPI-17-0770

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma
Hong Xu, Yueming Chen, Xueyan Dong and Xianjun Wang
Cancer Epidemiol Biomarkers Prev April 12 2018 DOI: 10.1158/1055-9965.EPI-17-0770
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Smoking and Prostate Cancer Survival
  • HPV seroprevalence and anal HPV in gay and bisexual men
  • NSAID use and colorectal cancer
Show more Research Article
  • Home
  • Alerts
  • Feedback
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement